Skip to main content
Premium Trial:

Request an Annual Quote

Two Ontario Labs Adopt Tm Bio's Respiratory Viral Panel

NEW YORK (GenomeWeb News) - Tm Bioscience today said two labs in Ontario are using its ID-TAG Respiratory Viral Panel to detect acute respiratory pathogens.
 
The company said St. Joseph's Healthcare in Hamilton, Ontario, and London Health Sciences Center, in London, Ontario, are using its RVP, which is designed to detect "the majority of strains and subtypes of respiratory viruses" including those that cause influenza strains A and B.
 
Tm Bio's president and CEO, Greg Hines, said the deals reflect "the growing recognition of the value of our approach to infectious disease testing."
 
Jim Mahony, a lab director at St. Joseph's, said the RVP test "rapidly detects and identifies specific pathogens from a long list of potential respiratory viruses," which doctors can use to determine treatment methods.
 
Financial terms of the agreements were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.